This trial is active, not recruiting.

Condition arthritis
Treatment vocational rehabilitation intervention
Sponsor Boston University
Collaborator U.S. Department of Education
Start date June 2011
End date December 2015
Trial size 300 participants
Trial identifier NCT01387100, H133B100003-1


The purpose of this study is to explore the effects of a brief vocational rehabilitation intervention on individuals with arthritis who are concerned about their ability to remain employed.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking single blind (investigator)
Primary purpose supportive care
This group will be assigned a physical therapist or occupational therapist to meet with followed by 2 phone consultations.
vocational rehabilitation intervention
Physical or occupational therapist will deliver a vocational rehabilitation intervention using the Work Experience Survey for Persons with Rheumatic Conditions (WES-RC) assessment tool to assess subject's health and vocational background as well as work barriers.
(No Intervention)
This is the control group. This group will not receive the vocational rehabilitation intervention from an occupational or physical therapist. They will receive written information regarding job accommodations and disability advocacy.

Primary Outcomes

Change in work status
time frame: Baseline, 6, 12, 24 month follow up

Eligibility Criteria

Male or female participants from 25 years up to 63 years old.

Inclusion Criteria: - Live or work in eastern Massachusetts - Age 25-63 years - Risk of work loss due to arthritis - Arthritis - Chronic back pain - Currently employed Exclusion Criteria: - Unemployed - No arthritis

Additional Information

Official title Efficacy of a Modified Vocational Rehabilitation Intervention for Work Disability
Principal investigator Julie Keysor, PhD
Trial information was received from ClinicalTrials.gov and was last updated in February 2015.
Information provided to ClinicalTrials.gov by Boston University.